These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12897976)

  • 41. Antibody detection of SARS-CoV spike and nucleocapsid protein.
    Chang MS; Lu YT; Ho ST; Wu CC; Wei TY; Chen CJ; Hsu YT; Chu PC; Chen CH; Chu JM; Jan YL; Hung CC; Fan CC; Yang YC
    Biochem Biophys Res Commun; 2004 Feb; 314(4):931-6. PubMed ID: 14751221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination and application of immunodominant regions of SARS coronavirus spike and nucleocapsid proteins recognized by sera from different animal species.
    Yu M; Stevens V; Berry JD; Crameri G; McEachern J; Tu C; Shi Z; Liang G; Weingartl H; Cardosa J; Eaton BT; Wang LF
    J Immunol Methods; 2008 Feb; 331(1-2):1-12. PubMed ID: 18191140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model.
    Miyoshi-Akiyama T; Ishida I; Fukushi M; Yamaguchi K; Matsuoka Y; Ishihara T; Tsukahara M; Hatakeyama S; Itoh N; Morisawa A; Yoshinaka Y; Yamamoto N; Lianfeng Z; Chuan Q; Kirikae T; Sasazuki T
    J Infect Dis; 2011 Jun; 203(11):1574-81. PubMed ID: 21592986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies.
    Faber M; Lamirande EW; Roberts A; Rice AB; Koprowski H; Dietzschold B; Schnell MJ
    J Gen Virol; 2005 May; 86(Pt 5):1435-1440. PubMed ID: 15831955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An ELISA for antibodies against infectious bronchitis virus using an S1 spike polypeptide.
    Wang CH; Hong CC; Seak JC
    Vet Microbiol; 2002 Apr; 85(4):333-42. PubMed ID: 11856583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.
    Woo PC; Lau SK; Tsoi HW; Chen ZW; Wong BH; Zhang L; Chan JK; Wong LP; He W; Ma C; Chan KH; Ho DD; Yuen KY
    Vaccine; 2005 Oct; 23(42):4959-68. PubMed ID: 15993989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus.
    Tripet B; Kao DJ; Jeffers SA; Holmes KV; Hodges RS
    J Struct Biol; 2006 Aug; 155(2):176-94. PubMed ID: 16697221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.
    He Y; Li J; Heck S; Lustigman S; Jiang S
    J Virol; 2006 Jun; 80(12):5757-67. PubMed ID: 16731915
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein.
    Wen K; Mei YB; Qiu LW; Liao ZY; Yuen KY; Che XY
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):1-6. PubMed ID: 14724082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine.
    He Y; Li J; Du L; Yan X; Hu G; Zhou Y; Jiang S
    Vaccine; 2006 Jun; 24(26):5498-508. PubMed ID: 16725238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SARS vaccine development.
    Jiang S; He Y; Liu S
    Emerg Infect Dis; 2005 Jul; 11(7):1016-20. PubMed ID: 16022774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.
    Zhi Y; Kobinger GP; Jordan H; Suchma K; Weiss SR; Shen H; Schumer G; Gao G; Boyer JL; Crystal RG; Wilson JM
    Virology; 2005 Apr; 335(1):34-45. PubMed ID: 15823604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.
    Chen Z; Zhang L; Qin C; Ba L; Yi CE; Zhang F; Wei Q; He T; Yu W; Yu J; Gao H; Tu X; Gettie A; Farzan M; Yuen KY; Ho DD
    J Virol; 2005 Mar; 79(5):2678-88. PubMed ID: 15708987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assembly of human severe acute respiratory syndrome coronavirus-like particles.
    Ho Y; Lin PH; Liu CY; Lee SP; Chao YC
    Biochem Biophys Res Commun; 2004 Jun; 318(4):833-8. PubMed ID: 15147946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: perspective for SARS vaccine development.
    Choy WY; Lin SG; Chan PK; Tam JS; Lo YM; Chu IM; Tsai SN; Zhong MQ; Fung KP; Waye MM; Tsui SK; Ng KO; Shan ZX; Yang M; Wu YL; Lin ZY; Ngai SM
    Clin Chem; 2004 Jun; 50(6):1036-42. PubMed ID: 15044316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The expression and activity detection of a variant N protein of SARS-CoV].
    Qi Y; Zheng Y; Shu CL; Jiang L; Hu Y; Mao PY; Cheng Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jul; 20(4):422-4. PubMed ID: 15207085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins.
    Haynes LM; Miao C; Harcourt JL; Montgomery JM; Le MQ; Dryga SA; Kamrud KI; Rivers B; Babcock GJ; Oliver JB; Comer JA; Reynolds M; Uyeki TM; Bausch D; Ksiazek T; Thomas W; Alterson H; Smith J; Ambrosino DM; Anderson LJ
    Clin Vaccine Immunol; 2007 Mar; 14(3):331-3. PubMed ID: 17229882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus.
    Zhao J; Wang W; Yuan Z; Jia R; Zhao Z; Xu X; Lv P; Zhang Y; Jiang C; Gao XM
    Virology; 2007 Mar; 359(2):362-70. PubMed ID: 17055551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A strategy for searching antigenic regions in the SARS-CoV spike protein.
    Ren Y; Zhou Z; Liu J; Lin L; Li S; Wang H; Xia J; Zhao Z; Wen J; Zhou C; Wang J; Yin J; Xu N; Liu S
    Genomics Proteomics Bioinformatics; 2003 Aug; 1(3):207-15. PubMed ID: 15629033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein.
    Zhong X; Yang H; Guo ZF; Sin WY; Chen W; Xu J; Fu L; Wu J; Mak CK; Cheng CS; Yang Y; Cao S; Wong TY; Lai ST; Xie Y; Guo Z
    J Virol; 2005 Mar; 79(6):3401-8. PubMed ID: 15731234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.